Keyword Connections

toll-like receptors

Journals

3

1 Frontiers in immunology

2 journal of nanobiotechnology

3 literature and medicine

Research Groups

0

No Research Group Connected

Bibliographies

17

1 The Challenge of Teaching Essential Immunology Laboratory Skills to Undergraduates in One Month-Experience of an Osteoimmunology Course on TLR Activation.

2 Rash Reading: Rethinking Virginia Woolf's On Being Ill.

3 Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice.

4 the tak1→ikkβ→tpl2→mkk1/mkk2 signaling cascade regulates il-33 expression in cystic fibrosis airway epithelial cells following infection by pseudomonas aeruginosa

5 deconvolution of the response to bacillus calmette–guérin reveals nf-κb-induced cytokines as autocrine mediators of innate immunity

6 rage-mediated inflammation, type 2 diabetes and diabetic vascular complication

7 role of polymorphisms of toll-like receptor (tlr) 4, tlr9, toll-interleukin 1 receptor domain containing adaptor protein (tirap) and fcgr2a genes in malaria susceptibility and severity in burundian children

8 dual role of toll-like receptors in human and experimental asthma models

9 corrigendum: irak4 deficiency in a patient with recurrent pneumococcal infections: case report and review of the literature

10 udenafil, a phosphodiesterase 5 inhibitor, reduces body weight in high-fat-fed mice

11 higher expression of toll-like receptors 3, 7, 8, and 9 in pityriasis rosea

12 targeting and recognition of toll-like receptors by plant and pathogen lectins

13 decreased secondary lesion growth and attenuated immune response after traumatic brain injury in tlr2/4−/− mice

14 toll-like receptors and cancer: myd88 mutation and inflammation

15 the role of toll-like receptors in skin diseases

16 candidate gene analysis of ocular toxoplasmosis in brazil: evidence for a role for toll-like receptor 9 (tlr9)

17 Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways